Epoch Investment Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137M Buy
545,050
+39,745
+8% +$9.89M 0.83% 26
2025
Q4
$139M Sell
505,305
-20,594
-4% -$5.63M 0.79% 37
2025
Q3
$138M Buy
525,899
+164,634
+46% +$40M 0.76% 40
2025
Q2
$79M Buy
361,265
+31,472
+10% +$6.73M 0.41% 95
2025
Q1
$73.8M Buy
329,793
+57,268
+21% +$15.8M 0.38% 99
2024
Q4
$89.3M Buy
272,525
+9,981
+4% +$3.14M 0.43% 80
2024
Q3
$78.8M Sell
262,544
-7,131
-3% -$2.18M 0.35% 113
2024
Q2
$88.8M Buy
269,675
+9,156
+4% +$3.24M 0.41% 85
2024
Q1
$103M Buy
260,519
+37,051
+17% +$13.7M 0.46% 74
2023
Q4
$78.7M Buy
223,468
+99,076
+80% +$35.1M 0.36% 92
2023
Q3
$46.7M Sell
124,392
-7,180
-5% -$2.78M 0.3% 120
2023
Q2
$50.3M Sell
131,572
-2,842
-2% -$1.02M 0.29% 121
2023
Q1
$46.6M Sell
134,414
-1,783
-1% -$521K 0.28% 124
2022
Q4
$32.1M Buy
136,197
+63,185
+87% +$15M 0.19% 165
2022
Q3
$18M Buy
73,012
+674
+0.9% +$205K 0.12% 201
2022
Q2
$21.9M Buy
72,338
+855
+1% +$278K 0.13% 200
2022
Q1
$29.4M Buy
71,483
+18,690
+35% +$7.32M 0.14% 181
2021
Q4
$24.8M Sell
52,793
-376
-0.7% -$162K 0.13% 189
2021
Q3
$22.6M Buy
53,169
+1,560
+3% +$658K 0.13% 193
2021
Q2
$18.5M Buy
51,609
+873
+2% +$288K 0.1% 202
2021
Q1
$14.3M Sell
50,736
-94
-0.2% -$26.9K 0.07% 219
2020
Q4
$14.4M Buy
50,830
+1,816
+4% +$510K 0.07% 203
2020
Q3
$13.5M Buy
+49,014
New +$13M 0.07% 195

Other funds holding WST